Diabetes firm brings in additional USD 10m for phase III trial
![Photo: Malina Petr/AP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14262257.ece/ALTERNATES/schema-16_9/21103442260086-1920x1080we.jpg)
After another financing round has been completed, US-based Vtv Therapeutics has secured an additional USD 10m funding, this time from investment firm Cinpax, the biotech firm reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Diabetes firm Vtv Therapeutics announces new CEO
For subscribers